BridgeMD
New treatment option for Mild Traumatic Brain Injury, Concussion
Official title Symptom Exacerbation Following Mental Imagery in Patients With Persistent Post-Concussive Symptoms
ClinicalTrials.gov ID: NCT07166536
What this study is testing
- What it's testing
- Background: Mild Traumatic Brain Injury (mTBI) often results in persistent emotional, cognitive, and somatic symptoms-such as headaches and dizziness. These symptoms impose a significant burden, yet their underlying mechanisms remain unclear.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Current patients of Reut Rehabilitation Hospital or individuals who were discharged from the hospital within the past 12 months.
- Diagnosis of mild Traumatic Brain Injury, concussion, blast injury, or cervical whiplash injury.
- More than 3 months since the event.
- Presence of headaches and/or dizziness that began after the injury and have persisted continuously or intermittently.
- Exclusion of other potential causes of headaches, such as non-healed fractures, chronic inflammation/infection, increased intracranial pressure, or...
You likely can't join if
- Significant cognitive impairment preventing informed consent (Mini-Mental State Examination score \<20 or Montreal Cognitive Assessment score \<20...
- Diagnosed central neurological conditions such as multiple sclerosis, Parkinson's disease, stroke, or brain tumor.
- Presence of known pyramidal or extrapyramidal neurological signs.
- Significant language impairment interfering with communication.
- Psychiatric disorders significantly affecting communication.
- Use of vestibular-suppressant medication (e.g., Cinnarizine) with an inability or unwillingness to discontinue treatment 24 hours prior to testing...
See the full eligibility criteria
- Current patients of Reut Rehabilitation Hospital or individuals who were discharged from the hospital within the past 12 months.
- Diagnosis of mild Traumatic Brain Injury, concussion, blast injury, or cervical whiplash injury.
- More than 3 months since the event.
- Presence of headaches and/or dizziness that began after the injury and have persisted continuously or intermittently.
- Exclusion of other potential causes of headaches, such as non-healed fractures, chronic inflammation/infection, increased intracranial pressure, or meningeal injury.
- Headache intensity of at least 3/10 on the VAS scale.
- Significant cognitive impairment preventing informed consent (Mini-Mental State Examination score \<20 or Montreal Cognitive Assessment score \<20, as per IRB requirements).
- Diagnosed central neurological conditions such as multiple sclerosis, Parkinson's disease, stroke, or brain tumor.
- Presence of known pyramidal or extrapyramidal neurological signs.
- Significant language impairment interfering with communication.
- Psychiatric disorders significantly affecting communication.
- Use of vestibular-suppressant medication (e.g., Cinnarizine) with an inability or unwillingness to discontinue treatment 24 hours prior to testing. Withdrawal Criteria: 1\. Oculomotor dysfunction affecting multiple...
The study team makes the final eligibility decision.
Where it's taking place
- Tel Aviv, Israel
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tel Aviv, Israel. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.